Comparative efficacy and safety of Chinese patent medicines as an adjunctive therapy for diabetic peripheral neuropathy: systematic review and network meta-analysis of randomized controlled trials

• Main Authors: Qun Wang (Author), Hui Xie (Author), Zihong Wang (Author), Runyun Huang (Author), Min Xu (Author), Yongjun Li (Author), Lingling Shan (Author), Hongyan Zhang (Author), Xianghong Liu (Author), Hongxing Zhang (Author), Yunsheng Xu (Author), Shiguang Sun (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Context Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes mellitus. Chinese patent medicines (CPMs) are widely used in clinical practice to treat DPN.Objective This study aims to summarize the latest evidence on the harms and benefits of CPMs as adjunctive therapy for...